Before you sell to, join or invest in Araceli Biosciences Inc.
MentionFox check on Araceli Biosciences Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/araceli-biosciences-inc-form-d-000004
Check Araceli Biosciences Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Araceli Biosciences Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Araceli Biosciences Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-03.
Araceli Biosciences Inc. filed a Form D notice of an exempt securities offering with the SEC on November 3, 2026. The filing reports $2.53M sold. Its industry group is Other Technology. It names Matt Beaudet (Executive Officer, Director), Shawn MacDonald (Executive Officer), William Cortelyou (Director) (SEC Form D, November 3, 2026).
Selling to Araceli Biosciences Inc.? See who runs it and how to reach them, plus this week's 43 other newly funded companies.
Is this your company?
Sell to companies like Araceli Biosciences Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-11-03 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Araceli Biosciences Inc.
Free to see. No signup.
Get an email when Araceli Biosciences Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Araceli Biosciences Inc. raises, hires or launches. No email unless you switch it on.
Watch Araceli Biosciences Inc. →Get the full cited report on Araceli Biosciences Inc.
What the filing shows about Araceli Biosciences Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Araceli Biosciences Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Araceli Biosciences Inc.'s address as 7405 Sw Tech Center Drive, Suite A160, Tigard, OR 97223-8080.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Araceli Biosciences Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Araceli Biosciences Inc. See pricing
Araceli Biosciences Inc. is a registered filer with the SEC (CIK 1975014) and has filed since 2023-04-26. 4 filings are on record, the latest on 2026-11-03.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Araceli Biosciences Inc.'s Form D of 2026-11-03 names Matt Beaudet, Shawn MacDonald, William Cortelyou and 6 more as its officers, directors or promoters.
Its new offerings report $7.28M sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 3855 filings in Other Technology, totalled by week. The dot is this raise, $2.53M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Matt Beaudet is named as Executive Officer and Director on the Form D that Araceli Biosciences Inc. filed with the SEC on 3 November 2026, one of 9 people that filing names.
Shawn MacDonald is named as Executive Officer on the Form D that Araceli Biosciences Inc. filed with the SEC on 3 November 2026, one of 9 people that filing names.
William Cortelyou is named as Director on the Form D that Araceli Biosciences Inc. filed with the SEC on 3 November 2026, one of 9 people that filing names.
J. William Freytag is named as Director on the Form D that Araceli Biosciences Inc. filed with the SEC on 3 November 2026, one of 9 people that filing names.
Kirk Malloy is named as Director on the Form D that Araceli Biosciences Inc. filed with the SEC on 3 November 2026, one of 9 people that filing names.
Sean O'Neill is named as Director on the Form D that Araceli Biosciences Inc. filed with the SEC on 3 November 2026, one of 9 people that filing names.
Samraat Raha is named as Director on the Form D that Araceli Biosciences Inc. filed with the SEC on 3 November 2026, one of 9 people that filing names.
Bruce Rhine is named as Director on the Form D that Araceli Biosciences Inc. filed with the SEC on 3 November 2026, one of 9 people that filing names.
Christine Ann Tsingos is named as Director on the Form D that Araceli Biosciences Inc. filed with the SEC on 3 November 2026, one of 9 people that filing names.
9 people named on the filing — 2 holding an executive role and 7 as directors only.
Named as of the 2026-11-03 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Araceli Biosciences Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Araceli Biosciences Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Araceli Biosciences Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Araceli Biosciences Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Araceli Biosciences Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Araceli Biosciences Inc.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises, week of 2026-11-02 · AI and software raises in Portland
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/araceli-biosciences-inc-form-d-000004